APPLICATION
ANDA201150
TYPE
ANDA
ORIGINAL APPROVAL
2012-11-09
LATEST ACTION
2025-06-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
SILDENAFIL CITRATEDiscontinued
SILDENAFIL CITRATE EQ 20MG BASE · TABLET · ORAL
Approval history
2025-06-13Labeling · Supplement 11 · standardAP
2019-04-02Labeling · Supplement 9 · standardAP
2019-04-02Labeling · Supplement 7 · standardAP
2019-04-02Labeling · Supplement 3 · standardAP
2019-04-02Labeling · Supplement 6 · standardAP
2012-11-09Not Applicable · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.